SP140 limits type I interferon-driven pathology, preserving T cell motility and promoting resistance in tuberculosis
SP140 可限制 I 型干扰素驱动的病理，从而保持 T 细胞的运动能力并促进结核病的抵抗力。
期刊:
影响因子:
doi:10.64898/2025.12.05.692491
Caouaille, Maxime; Fromont, Léa; Shinkawa, Tomoyo; Faucher, Marion; Abdul Hamid, Aizat Iman; Mazères, Serge; Duvergé, Yaël; Lorreyte, Yohan; Näser, Emmanuelle; Behar, Samuel M; Lefrançais, Emma; Neyrolles, Olivier; Hudrisier, Denis
